Immuno-Oncology Combinations in Advanced RCC: Building on Recent Progress for Community Practices (1/26/2021)

Click the Take Course button to access the evaluation.

 

The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with renal cell carcinoma.

Immuno-Oncology Combinations in Advanced RCC: Building on Recent Progress for Community Practices (1/8/2021)

Click the Take Course button to access the evaluation.

 

The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with renal cell carcinoma.

Immuno-Oncology Combinations in Advanced RCC: Building on Recent Progress for Community Practices (1/6/2021)

Click the Take Course button to access the evaluation.

 

The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with renal cell carcinoma.

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Multiple Myeloma
Clinicians must understand the treatment evolution and guidelines for administration of available therapies in the context of the patient's therapeutic and disease history to navigation through the complex treatment landscape.
NCCN Pharmacy Updates: Updates on Targeted Therapy in the Treatment of Metastatic Colorectal Cancer
Systemic therapy options in metastatic CRC are continuously evolving and new treatments are becoming available with utilization of various biomarkers. There is a need to review the current landscape of treatment regimens and have an understanding of their place in therapy.
NCCN Pharmacy Updates: Updates in the Treatment of Pancreatic Adenocarcinoma
Systemic therapy options in metastatic pancreatic cancer are evolving, including increasing usage of maintenance therapies. There is a need to review the current landscape of treatment regimens and have an understanding of their place in therapy.
NCCN Pharmacy Updates: New Agents for Soft Tissue Sarcoma and Gastrointestinal Stromal Tumors
Pharmacists play a critical role in patient education, monitoring, and management of treatment-related toxicities and would benefit from a comprehensive review of novel treatments for soft tissue sarcomas and gastrointestinal stromal tumors.
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer
This tumor board will discuss how to select the most appropriate therapy for patients with lung cancer using a case-based format.
Immuno-Oncology Combinations in Advanced RCC: Building on Recent Progress for Community Practices (12/9/2020)

Click the Take Course button to access the evaluation.

 

The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with renal cell carcinoma.

New NCCN Guidelines for Pediatric Cancers: Multidisciplinary Management of Wilms Tumor (Nephroblastoma)
The NCCN Guidelines for Wilms tumor (nephroblastoma) are new guidelines that will address management of favorable histology Wilms tumor in children. Treatment needs to be carefully selected to maximize cure and minimize long-term toxicities, such as renal failure, cardiac toxicity, and hypertension, because these children with favorable histology Wilms tumor generally have long-term survival if they receive appropriate management.

Pages

Subscribe to RSS - Live Webinar